Skip to main content
Skip to section navigation
Skip to footer
About
Discover Mineralys
Purpose & Values
Our Team
Science
Lorundrostat
Aldosterone
Hypertension
Cardio-Renal-Metabolic Syndrome
Pipeline
Investors
Publications
Contact Us
Careers & Culture
Partnering
Contact Form
Menu
About
Discover Mineralys
Purpose & Values
Our Team
Science
Lorundrostat
Aldosterone
Hypertension
Cardio-Renal-Metabolic Syndrome
Pipeline
Investors
Publications
Contact Us
Careers & Culture
Partnering
Contact Form
Press Releases
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Email Alerts
SEC Filings
All SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Year
All Years
2025
2024
2023
2022
2021
Category
All Releases
Financial Releases
Apr 06, 2021 7:00 am EDT
Mineralys Therapeutics Closes $40 Million Series A Funding
Previous Page
arrow_back
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
rss_feed
News RSS
Email Alerts
Contacts
RSS News Feed
